Defiance Daily Target 2X Long HIMS ETF (NASDAQ:HIMZ) Trading Up 0.1% – Still a Buy?

Defiance Daily Target 2X Long HIMS ETF (NASDAQ:HIMZGet Free Report) traded up 0.1% during trading on Thursday . The stock traded as high as $45.84 and last traded at $44.24. 398,495 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 1,589,778 shares. The stock had previously closed at $44.18.

Defiance Daily Target 2X Long HIMS ETF Stock Performance

The stock has a market cap of $215.41 million, a price-to-earnings ratio of 137.04 and a beta of 4.81. The business has a 50-day simple moving average of $35.71 and a two-hundred day simple moving average of $45.84.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. XTX Topco Ltd acquired a new stake in Defiance Daily Target 2X Long HIMS ETF in the 4th quarter valued at $59,000. Jump Financial LLC bought a new position in shares of Defiance Daily Target 2X Long HIMS ETF in the 4th quarter valued at about $75,000. Prosperitas Financial LLC acquired a new stake in shares of Defiance Daily Target 2X Long HIMS ETF in the fourth quarter valued at about $116,000. Finally, HRT Financial LP acquired a new stake in shares of Defiance Daily Target 2X Long HIMS ETF in the fourth quarter valued at about $176,000.

About Defiance Daily Target 2X Long HIMS ETF

(Get Free Report)

The Defiance Daily Target 2X Long HIMS ETF (HIMZ) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of Hims & Hers Health Inc (HIMS), less fees and expenses, through derivatives like swap agreements HIMZ was launched on Mar 12, 2025 and is issued by Defiance.

Read More

Receive News & Ratings for Defiance Daily Target 2X Long HIMS ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long HIMS ETF and related companies with MarketBeat.com's FREE daily email newsletter.